NCT05689515 is a NA clinical trial of Mobile health app in HIV Antibody Positivity, sponsored by The University of Texas Health Science Center at San Antonio.

Who is sponsoring NCT05689515?

NCT05689515 is sponsored by The University of Texas Health Science Center at San Antonio.

What drugs are being tested in NCT05689515?

Interventions in NCT05689515: Mobile health app.

What condition does NCT05689515 study?

NCT05689515 studies HIV Antibody Positivity.

Is NCT05689515 still recruiting?

NCT05689515 is currently completed. Last updated 4 February 2025.

Last reviewed 2025-02-04 · How we verify

NCT05689515

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility of Positive Links for Youth Care Engagement Intervention

Completed NA Last updated 4 February 2025

What this trial tests

NA trial testing Mobile health app in HIV Antibody Positivity in 30 participants. Completed in 30 January 2025.

Timeline

2 February 2023

Primary endpoint
30 January 2025

30 January 2025

Quick facts

Lead sponsor	The University of Texas Health Science Center at San Antonio
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	30
Start date	2 February 2023
Primary completion	30 January 2025
Estimated completion	30 January 2025
Sites	1 location across United States

Drugs / interventions tested

Mobile health app

Conditions studied

HIV Antibody Positivity — all drugs for HIV Antibody Positivity →

Sponsor

The University of Texas Health Science Center at San Antonio

Who can join

Adults 18 to 29, any sex, with HIV Antibody Positivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A small pilot study to assess feasibility and acceptability of the PL4Y intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Mobile health app

Trials testing the same drug.

NCT05979571 — Developing and Testing an Educational Intervention Through Technological Platform to Support Exclusive Breastfeeding · NA · unknown
NCT04401332 — A Randomized Controlled Trial of AppS to Home Monitor Your Asthma · NA · completed

Other The University of Texas Health Science Center at San Antonio trials

Trials by the same sponsor.

NCT07280897 — SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial · NA · not yet recruiting
NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
NCT07056699 — SGLT2i, Pioglitazone, and Ketone Production in T1D · Phase 3 · not yet recruiting
NCT06609343 — Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis · Phase 1, PHASE2 · not yet recruiting
NCT07437053 — Sarcopenia in Chronic Kidney Disease (CKD) Patients · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05689515 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center at San Antonio
Last refreshed: 4 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05689515.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing